APA

Timmers S., de Ligt M., Phielix E., van de Weijer T., Hansen J., Moonen-Kornips E., Schaart G., Kunz I., Hesselink M. K. C., Schrauwen-Hinderling V. B. & Schrauwen P. (20171023). Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. : Diabetes care.

Chicago

Timmers Silvie, de Ligt Marlies, Phielix Esther, van de Weijer Tineke, Hansen Jan, Moonen-Kornips Esther, Schaart Gert, Kunz Iris, Hesselink Matthijs K C, Schrauwen-Hinderling Vera B and Schrauwen Patrick. 20171023. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. : Diabetes care.

Harvard

Timmers S., de Ligt M., Phielix E., van de Weijer T., Hansen J., Moonen-Kornips E., Schaart G., Kunz I., Hesselink M. K. C., Schrauwen-Hinderling V. B. and Schrauwen P. (20171023). Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. : Diabetes care.

MLA

Timmers Silvie, de Ligt Marlies, Phielix Esther, van de Weijer Tineke, Hansen Jan, Moonen-Kornips Esther, Schaart Gert, Kunz Iris, Hesselink Matthijs K C, Schrauwen-Hinderling Vera B and Schrauwen Patrick. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. : Diabetes care. 20171023.